Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

A marriage made to last in drug design

Many mechanisms can contribute to complex diseases such as metabolic diseases; thus, combination therapies may be required to target individual underlying pathological mechanisms. A new study combines glucagon-like peptide-1 (GLP1) and estrogen in a single molecule, allowing selective targeting of this conjugate to cells that express the GLP1 receptor. This strategy improves the metabolic profile of obese mice without the adverse side effects associated with estrogen therapy (pages 1847–1856).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A summary of the effects of GLP1, estrogen and a conjugated GLP1–estrogen compound.

Debbie Maizels


  1. Finan, B. et al. Nat. Med. 18, 1847–1856 (2012).

    Article  CAS  Google Scholar 

  2. Dietrich, M.O. & Horvath, T.L. Nat. Rev. Drug Discov. 11, 675–691 (2012).

    Article  CAS  Google Scholar 

  3. Zhang, Y. et al. Nature 372, 425–432 (1994).

    Article  CAS  Google Scholar 

  4. Halaas, J.L. et al. Science 269, 543–546 (1995).

    Article  CAS  Google Scholar 

  5. Dietrich, M.O. & Horvath, T.L. Eur. J. Neurosci. 30, 1688–1696 (2009).

    Article  Google Scholar 

  6. Gao, Q. & Horvath, T.L. Am. J. Physiol. Endocrinol. Metab. 294, E817–E826 (2008).

    Article  CAS  Google Scholar 

  7. Kalra, S.P. et al. Endocr. Rev. 20, 68–100 (1999).

    CAS  PubMed  Google Scholar 

  8. Gao, Q. et al. Nat. Med. 13, 89–94 (2007).

    Article  CAS  Google Scholar 

  9. Pinto, S. et al. Science 304, 110–115 (2004).

    Article  CAS  Google Scholar 

  10. Dietrich, M.O. et al. Nat. Neurosci. 15, 1108–1110 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Tamas L Horvath.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dietrich, M., Horvath, T. A marriage made to last in drug design. Nat Med 18, 1737–1738 (2012).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing